Laura J. Schumacher

In 2016, Laura J. Schumacher filed 35 disclosures, a level not seen since: 28 in 2017, 21 in 2018, then 9 to 18 a year. The record counts 192 filings published between March 2, 2016 and September 21, 2026, split between AbbVie Inc. (100, as Executive Vice President), General Dynamics Corp (69, as Director) and CrowdStrike Holdings, Inc. (23, as Director).

The 49 sales amount to EUR 68,587,339, yet their median is only EUR 52,461: a few much larger trades pull the total up. The largest dates from December 17, 2021 (EUR 20,401,296), followed by December 14, 2017 (EUR 11,796,129) and June 14, 2017 (EUR 4,980,478), all at AbbVie. A single purchase appears in the record: EUR 1,599,590 at AbbVie on September 16, 2019. There are also 118 share grants, 13 option exercises and 10 filings of another kind.

The median gap before publication is 2 days. The latest twelve months hold eleven filings, and none is a sale or a purchase.

The count of trades by Schumacher within 30 days of colleagues at AbbVie Inc. is 41, 25 and 19. In the same direction: 41, 24 and 19. The colleagues, in the same order: Richard A. Gonzalez, Timothy J. Richmond and Thomas A. Hurwich.